TY - JOUR
T1 - International travel
T2 - Recommendations for the HIV-infected patient
AU - Spacek, Lisa A.
AU - Quinn, Thomas C.
N1 - Funding Information:
17. Kaplan JE, Masur H, Holmes KK, et al.: Guidelines for prevent-ing opportunistic infection among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. MMWR Recomm Rep 2002, 51:1–52.
PY - 2004/10
Y1 - 2004/10
N2 - In order to prevent travel-related diseases in patients infected with HIV, pretravel planning that includes vaccination, chemoprophylaxis, and behavioral modification is recommended. Many HIV-infected individuals successfully treated with highly active antiretroviral therapy may travel safely. However, patients with reduced CD4 lymphocyte counts are at increased risk for bacterial, mycobacterial, viral, fungal, and parasitic infections. Recommendations for vaccination and chemoprophylaxis are based on immune status and risk of infection. The efficacy of vaccination is dependant on CD4 lymphocyte count; inactivated and polysaccharide vaccines are considered safe in this population. Behavioral modifications to prevent food- and water-borne disease are an important component of disease prevention. A travel-health practitioner should review travel duration, destination, and activities, and assess the risk-benefit ratio of vaccination and chemoprophylaxis, in order to reduce the likelihood of travel-associated illnes.
AB - In order to prevent travel-related diseases in patients infected with HIV, pretravel planning that includes vaccination, chemoprophylaxis, and behavioral modification is recommended. Many HIV-infected individuals successfully treated with highly active antiretroviral therapy may travel safely. However, patients with reduced CD4 lymphocyte counts are at increased risk for bacterial, mycobacterial, viral, fungal, and parasitic infections. Recommendations for vaccination and chemoprophylaxis are based on immune status and risk of infection. The efficacy of vaccination is dependant on CD4 lymphocyte count; inactivated and polysaccharide vaccines are considered safe in this population. Behavioral modifications to prevent food- and water-borne disease are an important component of disease prevention. A travel-health practitioner should review travel duration, destination, and activities, and assess the risk-benefit ratio of vaccination and chemoprophylaxis, in order to reduce the likelihood of travel-associated illnes.
UR - http://www.scopus.com/inward/record.url?scp=7944227075&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=7944227075&partnerID=8YFLogxK
U2 - 10.1007/s11908-004-0040-3
DO - 10.1007/s11908-004-0040-3
M3 - Review article
AN - SCOPUS:7944227075
SN - 1523-3847
VL - 6
SP - 399
EP - 403
JO - Current Infectious Disease Reports
JF - Current Infectious Disease Reports
IS - 5
ER -